Foamy virus

Molecular Detection of Human Viral Pathogens

Volumn , Issue , 2016, Pages 131-146

  Switzer, William M ^a   Heneine, Walid ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85052281417     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (133)

1. Taylor, L. H., Latham, S. M., and Woolhouse, M. E., Risk factors for human disease emergence, Philos. Trans. R. Soc. Lond. B Biol. Sci., 356, 983, 2001.
2. Heneine, W., et al., Human infection with foamy viruses, Curr. Top. Microbiol. Immunol., 277, 181, 2003.
3. Murphy, H. W., et al., Implications of simian retroviruses for captive primate population management and the occupational safety of primate handlers, J. Zoo Wildl. Med., 37, 219, 2006.
4. Wolfe, N. D., Switzer, W. M., and Heneine, W., Emergence of Novel Retroviruses (ASM Press, Washington, DC, 2006).
5. Murphy, H. W., Occupational exposure to zoonotic simian retroviruses: Health and safety implications for persons working with nonhuman primates, in Zoo and Wild Animal Medicine, ed. F. M. Miller (R. Saunders Elsevier, St. Louis, MO, 2008), 251-64.
6. Wolfe, N. D., Primate exposure and the emergence of novel retroviruses, in Primate Parasite Ecology, ed. M. H. Chapman (Cambridge University Press, Cambridge, 2009), 353-70.
7. Linial, M. L., et al., Retroviridae, in Virus Taxonomy, Seventh Report of the International Committee on Taxonomy of Viruses, eds. C. M. Fauquet (Elsevier/Academic Press, London, 2004), 421-40.
8. Coffin, J., Hughes, S., and Varmus, H., Retroviruses (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1997).
9. Rethwilm, A., Regulation of foamy virus gene expression, Curr. Top. Microbiol. Immunol., 193, 1, 1995.
10. Lochelt, M., Foamy virus transactivation and gene expression, Curr. Top. Microbiol. Immunol., 277, 27, 2003.
11. Campbell, M., Eng, C., and Luciw, P. A., The simian foamy virus type 1 transcriptional transactivator (Tas) binds and activates an enhancer element in the gag gene, J. Virol., 70, 6847, 1996.
12. Delebecque, F., et al., Restriction of foamy viruses by APOBEC cytidine deaminases, J. Virol., 80, 605, 2006.
13. Lochelt, M., et al., The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein, Proc. Natl. Acad. Sci. USA, 102, 7982, 2005.
14. Perkovic, M., et al., Species-specific inhibition of APOBEC3C by the prototype foamy virus protein Bet, J. Biol. Chem., 284, 5819, 2009.
15. Russell, R. A., et al., Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors, J. Virol., 79, 8724, 2005.
16. Callahan, M. E., et al., Persistent zoonotic infection of a human with simian foamy virus in the absence of an intact orf-2 accessory gene, J. Virol., 73, 9619, 1999.
17. Cullen, B. R., Human Retroviruses (Oxford University Press, New York, 1993).
18. Yu, S. F., et al., Human foamy virus replication: A pathway distinct from that of retroviruses and hepadnaviruses, Science, 271, 1579, 1996.
19. Linial, M. L., Foamy viruses are unconventional retroviruses, J. Virol., 73, 1747, 1999.
20. Moebes, A., et al., Human foamy virus reverse transcription that occurs late in the viral replication cycle, J. Virol., 71, 7305, 1997.
21. Yu, S. F., Sullivan, M. D., and Linial, M. L., Evidence that the human foamy virus genome is DNA, J. Virol., 73, 1565, 1999.
22. Lecellier, C. H., and Saib, A., Foamy viruses: Between retroviruses and pararetroviruses, Virology, 271, 1, 2000.
23. Hooks, J. J., and Gibbs, C. J., Jr., The foamy viruses, Bacteriol. Rev., 39, 169, 1975.
24. Meiering, C. D., and Linial, M. L., Historical perspective of foamy virus epidemiology and infection, Clin. Microbiol. Rev., 14, 165, 2001.
25. Murray, S. M., and Linial, M. L., Foamy virus infection in primates, J. Med. Primatol., 35, 225, 2006.
26. Neumann-Haefelin, D., et al., Foamy viruses, Intervirology, 35, 196, 1993.
27. Wilk, T., et al., The intact retroviral Env glycoprotein of human foamy virus is a trimer, J. Virol., 74, 2885, 2000.
28. Jones-Engel, L., et al., Temple monkeys and health implications of commensalism, Kathmandu, Nepal, Emerg. Infect. Dis., 12, 900, 2006.
29. Calattini, S., et al., Natural simian foamy virus infection in wild-caught gorillas, mandrills and drills from Cameroon and Gabon, J. Gen. Virol., 85, 3313, 2004.
30. Hussain, A. I., et al., Screening for simian foamy virus infection by using a combined antigen Western blot assay: Evidence for a wide distribution among Old World primates and identification of four new divergent viruses, Virology, 309, 248, 2003.
31. Leendertz, F. H., et al., Interspecies transmission of simian foamy virus in a natural predator-prey system, J. Virol., 82, 7741, 2008.
32. Liu, W., et al., Molecular ecology and natural history of simian foamy virus infection in wild-living chimpanzees, PLoS Pathog., 4, e1000097, 2008.
33. Switzer, W. M., et al., Ancient co-speciation of simian foamy viruses and primates, Nature, 434, 376, 2005.
34. Mergia, A., Leung, N. J., and Blackwell, J., Cell tropism of the simian foamy virus type 1 (SFV-1), J. Med. Primatol., 25, 2, 1996.
35. Yu, S. F., Stone, J., and Linial, M. L., Productive persistent infection of hematopoietic cells by human foamy virus, J. Virol., 70, 1250, 1996.
36. McClure, M. O., et al., Isolation of a new foamy retrovirus from orangutans, J. Virol., 68, 7124, 1994.
37. Falcone, V., et al., Sites of simian foamy virus persistence in naturally infected African green monkeys: Latent provirus is ubiquitous, whereas viral replication is restricted to the oral mucosa, Virology, 257, 74, 1999.
38. Schweizer, M., et al., Genetic stability of foamy viruses: Longterm study in an African green monkey population, J. Virol., 73, 9256, 1999.
39. Calattini, S., et al., Modes of transmission and genetic diversity of foamy viruses in a Macaca tonkeana colony, Retrovirology, 3, 23, 2006.
40. Blewett, E. L., et al., Simian foamy virus infections in a baboon breeding colony, Virology, 278, 183, 2000.
41. Calattini, S., et al., Detection and molecular characterization of foamy viruses in Central African chimpanzees of the Pan troglodytes troglodytes and Pan troglodytes vellerosus subspecies, J. Med. Primatol., 35, 59, 2006.
42. Switzer, W. M., et al., Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates, J. Virol., 78, 2780, 2004.
43. Broussard, S. R., et al., Characterization of new simian foamy viruses from African nonhuman primates, Virology, 237, 349, 1997.
44. Achong, B. G., Mansell, P. W., and Epstein, M. A., A new human virus in cultures from a nasopharyngeal carcinoma, J. Pathol., 103, 18, 1971.
45. Achong, B. G., et al., An unusual virus in cultures from a human nasopharyngeal carcinoma, J. Natl. Cancer Inst., 46, 299, 1971.
46. Herchenroder, O., et al., Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): High homology to human foamy virus (HFV), Virology, 201, 187, 1994.
47. Cameron, K. R., Birchall, S. M., and Moses, M. A., Isolation of foamy virus from patient with dialysis encephalopathy, Lancet, 2, 796, 1978.
48. Achong, B. G., and Epstein, M. A., Preliminary seroepidemiological studies on the human syncytial virus, J. Gen. Virol., 40, 175, 1978.
49. Achong, B. G., and Epstein, M. A., Naturally occurring antibodies to the human syncytial virus in West Africa, J. Med. Virol., 11, 53, 1983.
50. Gow, J. W., et al., Search for retrovirus in the chronic fatigue syndrome, J. Clin. Pathol., 45, 1058, 1992.
51. Hunsmann, G., Flügel, R. M., and Walder, R., Retroviral antibodies in Indians, Nature, 345, 120, 1990.
52. Lagaye, S., et al., Human spumaretrovirus-related sequences in the DNA of leukocytes from patients with Graves disease, Proc. Natl. Acad. Sci. USA, 89, 10070, 1992.
53. Loh, P. C., Matsuura, F., and Mizumoto, C., Seroepidemiology of human syncytial virus: Antibody prevalence in the Pacific, Intervirology, 13, 87, 1980.
54. Mahnke, C., et al., Human spumavirus antibodies in sera from African patients, Arch. Virol., 123, 243, 1992.
55. Muller, H. K., et al., The prevalence of naturally occurring antibodies to human syncytial virus in East African populations, J. Gen. Virol., 47, 399, 1980.
56. Saib, A., et al., Human foamy virus infection in myasthenia gravis, Lancet, 343, 666, 1994.
57. Tamura, N., and Kira, S., Human foamy virus and familial Mediterranean fever in Japan, JAMA, 274, 1509, 1995.
58. Wallen, W. C., et al., Attempt to isolate infectious agent from bone-marrow of patients with multiple sclerosis, Lancet, 2, 414, 1979.
59. Weiss, R. A., Foamy retroviruses. A virus in search of a disease, Nature, 333, 497, 1988.
60. Werner, J., and Gelderblom, H., Isolation of foamy virus from patients with de Quervain thyroiditis, Lancet, 2, 258, 1979.
61. Westarp, M. E., et al., Retroviral synthetic peptide serum antibodies in human sporadic amyotrophic lateral sclerosis, Peptides, 15, 207, 1994.
62. Westarp, M. E., et al., Human spuma retrovirus antibodies in amyotrophic lateral sclerosis, Neurol. Psychiatr. Brain Res., 1, 1, 1992.
63. Wick, G., et al., Human foamy virus antigens in thyroid tissue of Graves' disease patients, Int. Arch. Allergy Immunol., 99, 153, 1992.
64. Wick, G., et al., Possible role of human foamy virus in Graves' disease, Intervirology, 35, 101, 1993.
65. Baum, K. F., Absence of antibody to human spumaretrovirus in patients with chronic fatigue syndrome, Clin. Infect. Dis., 14, 623, 1992.
66. Brown, P., Nemo, G., and Gajdusek, D. C., Human foamy virus: Further characterization, seroepidemiology, and relationship to chimpanzee foamy viruses, J. Infect. Dis., 137, 421, 1978.
67. Debons-Guillemin, M. C., et al., No evidence of spumaretrovirus infection markers in 19 cases of De Quervain's thyroiditis, AIDS Res. Hum. Retroviruses, 8, 1547, 1992.
68. Folks, T. M., et al., Investigation of retroviral involvement in chronic fatigue syndrome, Ciba Foundation Symposium 173, 160; discussion 166, 1993.
69. Gunn, W. J., Connell, D. B., and Randall, B., Epidemiology of chronic fatigue syndrome: The Centers for Disease Control Study, Ciba Foundation Symposium 173, 83; discussion 93, 1993.
70. Heneine, W., et al., Absence of evidence for human spumaretrovirus sequences in patients with Graves' disease, J. AIDS Hum. Retrovirol., 9, 99, 1995.
71. Kuzmenok, O. I., et al., Myasthenia gravis accompanied by thymomas not related to foamy virus genome in Belarusian's patients, Int. J. Neurosci., 117, 1603, 2007.
72. Li, H., et al., Absence of human T-cell lymphotropic virus type I and human foamy virus in thymoma, Br. J. Cancer, 90, 2181, 2004.
73. Schweizer, M., et al., Absence of foamy virus DNA in Graves' disease, AIDS Res. Hum. Retroviruses, 10, 601, 1994.
74. Simonsen, L., et al., Absence of evidence for infection with the human spuma retrovirus in an outbreak of Meniere-like vertiginous illness in Wyoming, USA, Acta Otolaryngol., 114, 223, 1994.
75. Svenningsson, A., et al., No evidence for spumavirus or oncovirus infection in relapsing-remitting multiple sclerosis, Ann. Neurol., 32, 711, 1992.
76. Yanagawa, T., et al., Absence of association between human spumaretrovirus and Graves' disease, 5, 379, 1995.
77. Schweizer, M., et al., Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: Appropriate testing fails to confirm suspected foamy virus prevalence in humans, AIDS Res. Hum. Retroviruses, 11, 161, 1995.
78. Ali, M., et al., No evidence of antibody to human foamy virus in widespread human populations, AIDS Res. Hum. Retroviruses, 12, 1473, 1996.
79. McClure, M. O., and Erlwein, O., Foamy viruses-Pathogenic or therapeutic potential, Rev. Med. Virol., 5, 229, 1995.
80. Heneine, W., et al., Lack of evidence for infection with known human and animal retroviruses in patients with chronic fatigue syndrome, Clin. Infect. Dis., 18, S121, 1994.
81. Heneine, W., et al., Identification of a human population infected with simian foamy viruses, Nat. Med., 4, 403, 1998.
82. Schweizer, M., et al., Simian foamy virus isolated from an accidentally infected human individual, J. Virol., 71, 4821, 1997.
83. Lerche, N. W., et al., Evidence of infection with simian type D retrovirus in persons occupationally exposed to nonhuman primates, J. Virol., 75, 1783, 2001.
84. Sandstrom, P. A., et al., Simian foamy virus infection among zoo keepers, Lancet, 355, 551, 2000.
85. von Laer, D., et al., Lymphocytes are the major reservoir for foamy viruses in peripheral blood, Virology, 221, 240, 1996.
86. Brooks, J. I., et al., Cross-species retroviral transmission from macaques to human beings, Lancet, 360, 387, 2002.
87. Wolfe, N. D., et al., Naturally acquired simian retrovirus infections in central African hunters, Lancet, 363, 932, 2004.
88. Calattini, S., et al., Simian foamy virus transmission from apes to humans, rural Cameroon, Emerg. Infect. Dis., 13, 1314, 2007.
89. Jones-Engel, L., et al., Primate-to-human retroviral transmission in Asia, Emerg. Infect. Dis., 11, 1028, 2005.
90. Jones-Engel, L., et al., Diverse contexts of zoonotic transmission of simian foamy viruses in Asia, Emerg. Infect. Dis., 14, 1200, 2008.
91. Switzer, W. M., et al., Coinfection with HIV-1 and simian foamy virus in west central Africans, J. Infect. Dis., 197, 1389, 2008.
92. Hooks, J. J., et al., Isolation of a new simian foamy virus from a spider monkey brain culture, Infect. Immun., 8, 804, 1973.
93. Thumer, L., et al., The complete nucleotide sequence of a New World simian foamy virus, Virology, 369, 191, 2007.
94. Barahona, H., et al., Isolation and characterization of lymphocyte associated foamy virus from a red uakari monkey (Cacajao rubicundus), J. Med. Primatol., 5, 253, 1976.
95. Boneva, R. S., et al., Clinical and virological characterization of persistent human infection with simian foamy viruses, AIDS Res. Hum. Retroviruses, 23, 1330, 2007.
96. Boneva, R. S., et al., Simian foamy virus infection in a blood donor, Transfusion, 42, 886, 2002.
97. Brooks, J. I., et al., Characterization of blood-borne transmission of simian foamy virus, Transfusion, 47, 162, 2007.
98. Khan, A. S., and Kumar, D., Simian foamy virus infection by whole-blood transfer in rhesus macaques: Potential for transfusion transmission in humans, Transfusion, 46, 1352, 2006.
99. Heneine, W., and Kuehnert, M. J., Preserving blood safety against emerging retroviruses, Transfusion, 46, 1276, 2006.
100. Schillaci, M., et al., Characterizing the threat to the blood supply associated with nonoccupational exposure to emerging simian retroviruses, Transfusion, 48, 398, 2008.
101. Apetrei, C., Robertson, D. L., and Marx, P. A., The history of SIVS and AIDS: Epidemiology, phylogeny and biology of isolates from naturally SIV infected non-human primates (NHP) in Africa, Front. Biosci., 9, 225, 2004.
102. Hahn, B. H., et al., AIDS as a zoonosis: Scientific and public health implications, Science, 287, 607, 2000.
103. Keele, B. F., et al., Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz, Nature, 460, 515, 2009.
104. Cummins, J. E., Jr., et al., Mucosal and systemic antibody responses in humans infected with simian foamy virus, J. Virol., 79, 13186, 2005.
105. Murray, S. M., et al., Replication in a superficial epithelial cell niche explains the lack of pathogenicity of primate foamy virus infections, J. Virol., 82, 5981, 2008.
106. Murray, S. M., et al., Expanded tissue targets for foamy virus replication with simian immunodeficiency virus-induced immunosuppression, J. Virol., 80, 663, 2006.
107. Schiffer, C., et al., Persistent infection with primate foamy virus type 1 increases human immunodeficiency virus type 1 cell binding via a Bet-independent mechanism, J. Virol., 78, 11405, 2004.
108. Rosenblum, L. L., et al., Differential susceptibility of retroviruses to nucleoside analogues, Antivir. Chem. Chemother., 12, 91, 2001.
109. Hartl, M. J., et al., AZT resistance of simian foamy virus reverse transcriptase is based on the excision of AZTMP in the presence of ATP, Nucleic Acids Res., 36, 1009, 2008.
110. Kretzschmar, B., et al., AZT-resistant foamy virus, Virology, 370, 151, 2008.
111. Saib, A., Non-primate foamy viruses, Curr. Top. Microbiol. Immunol., 277, 197, 2003.
112. Butera, S. T., et al., Survey of veterinary conference attendees for evidence of zoonotic infection by feline retroviruses, J. Am. Vet. Med. Assoc., 217, 1475, 2000.
113. Winkler, I. G., et al., A rapid streptavidin-capture ELISA specific for the detection of antibodies to feline foamy virus, J. Immunol. Methods, 207, 69, 1997.
114. Winkler, I. G., et al., Detection and molecular characterisation of feline foamy virus serotypes in naturally infected cats, Virology, 247, 144, 1998.
115. Winkler, I. G., Lochelt, M., and Flower, R. L., Epidemiology of feline foamy virus and feline immunodeficiency virus infections in domestic and feral cats: A seroepidemiological study, J. Clin. Microbiol., 37, 2848, 1999.
116. Brown, J., et al., Xenotransplantation and the risk of retroviral zoonosis, Trends Microbiol., 6, 411, 1998.
117. Macher, B. A., and Galili, U., The Galalpha1,3Galbeta1, 4GlcNAc-R (alpha-Gal) epitope: A carbohydrate of unique evolution and clinical relevance, Biochim. Biophys. Acta, 1780, 75, 2008.
118. Rother, R. P., et al., A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody, J. Exp. Med., 182, 1345, 1995.
119. Blewett, E. L., et al., Isolation of cytomegalovirus and foamy virus from the drill monkey (Mandrillus leucophaeus) and prevalence of antibodies to these viruses amongst wild-born and captive-bred individuals, Arch. Virol., 148, 423, 2003.
120. Khan, I. H., et al., Simultaneous detection of antibodies to six nonhuman-primate viruses by multiplex microbead immunoassay, Clin. Vaccine Immunol., 13, 45, 2006.
121. Romen, F., et al., Antibodies against Gag are diagnostic markers for feline foamy virus infections while Env and Bet reactivity is undetectable in a substantial fraction of infected cats, Virology, 345, 502, 2006.
122. Hahn, H., et al., Reactivity of primate sera to foamy virus Gag and Bet proteins, J. Gen. Virol., 75, 2635, 1994.
123. Khan, A. S., et al., Sensitive assays for isolation and detection of simian foamy retroviruses, J. Clin. Microbiol., 37, 2678, 1999.
124. Schweizer, M., and Neumann-Haefelin, D., Phylogenetic analysis of primate foamy viruses by comparison of pol sequences, Virology, 207, 577, 1995.
125. Allan, J. S., et al., Amplification of simian retroviral sequences from human recipients of baboon liver transplants, AIDS Res. Hum. Retroviruses, 14, 821, 1998.
126. Bieniasz, P. D., et al., A comparative study of higher primate foamy viruses, including a new virus from a gorilla, Virology, 207, 217, 1995.
127. Boni, J., Pyra, H., and Schupbach, J., Sensitive detection and quantification of particle-associated reverse transcriptase in plasma of HIV-1-infected individuals by the product-enhanced reverse transcriptase (PERT) assay, J. Med. Virol., 49, 23, 1996.
128. Heneine, W., et al., Detection of reverse transcriptase by a highly sensitive assay in sera from persons infected with human immunodeficiency virus type 1, J. Infect. Dis., 171, 1210, 1995.
129. Garcia Lerma, J., et al., A rapid non-culture-based assay for clinical monitoring of phenotypic resistance of human immunodeficiency virus type 1 to lamivudine (3TC), Antimicrob. Agents Chemother., 43, 264, 1999.
130. Garcia Lerma, J. G., and Heneine, W., [Quantification of HIV-1 viral load by the measurement of reverse transcriptase activity], Med. Clin. (Barc), 110, 453, 1998.
131. Garcia Lerma, J. G., et al., Measurement of human immunodeficiency virus type 1 plasma virus load based on reverse transcriptase (RT) activity: Evidence of variabilities in levels of virion-associated RT, J. Infect. Dis., 177, 1221, 1998.
132. Vassilopoulos, G., Josephson, N. C., and Trobridge, G., Development of foamy virus vectors, Methods Mol. Med., 76, 545, 2003.
133. Vassilopoulos, G., and Rethwilm, A., Foamy virus vectors: The usefulness of a perfect parasite, Gene Ther., 15, 1299, 2008.